

Craftsmanship Pharmaceuticals Kangda Sifang
2026-07-13 10:00:00
Click:


Recently, Mr. MOHAMMED AHMED HIZAM MOHAMMED, Inspector of the Ministry of Health of the Republic of Sudan, headed a special inspection team to our company and conducted an official four‑day factory audit from July 6 to 9, 2026. Following comprehensive and high‑standard verification, all management, production and quality control procedures of our company comply with Sudan’s market access regulations. The successful completion of this audit has laid a solid compliance foundation for the bulk entry of our company’s foreign‑trade products into the Sudanese market.

At the opening audit meeting, Liu Zhengchao, Chairman and General Manager of the Company, together with heads of various functional departments, held in‑depth discussions with the Sudanese inspection team and distributors. During the meeting, our company reported on corporate overview and GMP management practices. It systematically presented core product categories, standardized production workflows and the whole‑chain quality management system, and elaborated on key control measures including raw material management, workshop production, finished‑product testing and warehousing traceability, fully demonstrating the company’s standardized operational strength and commitment to quality for overseas markets.

![]() | ![]() |
![]() | ![]() |
Throughout the audit, in strict accordance with Sudanese health regulatory standards, the Sudanese inspection team conducted on‑site inspections of production workshops, laboratories, raw‑material warehouses and finished‑product warehouses. They carefully reviewed system documents, production records and test reports, and interviewed front‑line management and operating staff. The team fully recognized the end‑to‑end product quality control, clean production environment and sound traceability system, affirming that the company’s quality system operates in a standardized and well‑implemented manner and fully meets Sudan’s import regulatory requirements.


The successful passing of this official Sudanese factory audit represents authoritative recognition by an overseas regulatory authority of our product quality and comprehensive management capability, opening the critical access channel for our products to be exported to Sudan. To date, the company has obtained 73 overseas registration certificates. Its products are exported to Central Asia, West Asia, Southeast Asia, Africa, South America and other regions. Having undergone on‑site inspections by drug regulatory authorities of multiple countries, the company boasts solid experience in pharmaceutical export registration, production and quality management.
Moving forward, the company will keep benchmarking against international health regulatory standards and continuously optimize its quality management system. Timely rectification and improvement will be implemented for issues identified in the audit. With reliable product quality, the company will further expand foreign‑trade markets in Africa, steadily advance its internationalization strategy, and continuously enhance the global reputation of “Made in China”.
-END-